Comparison of inhibitory effects of three natriuretic peptides on the proliferation of pulmonary artery smooth muscle cells of rats

Acta Physiologica Sinica

Volumn 52, Issue 3, 2000, Pages 252-254

  Dong, Ming Qing ^a   Zhu, Miao Zhang ^a   Yu, Jun ^a   Shang, Li Jun ^a   Feng, Hua Song ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atrial natriuretic peptide (ANP); C type natriuretic peptide (CNP); Proliferation; Pulmonary artery; Vascular smooth muscle cells (PASMCS); Vasonatrin peptide (VNP)

Indexed keywords

ATRIAL NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; VENTRICULAR NATRIURETIC PEPTIDE, EEL;

ANIMAL; ARTICLE; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; FEMALE; MALE; PULMONARY ARTERY; RAT; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CELL DIVISION; CELLS, CULTURED; FEMALE; MALE; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC PEPTIDE, C-TYPE; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0039923512     PISSN: 03710874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Wei CM, Kim CH, Miller VM et al. A unique synthetic natriuretic and vasorelaxing peptide. J Clin Invest, 1993, 92: 2048-2052.
2. Feng HS, Zang YM, Zhu MZ et al. Vasorelaxing effect of vasonatrin peptide on pulmonary artery in rats. Chin J Cardiac Func, 1998, 10 (2): 69-71 (in Chinese with English abstract).
3. Arjona AA, Hsu CA, Wrenn DS et al. Effects of natriuretic peptides on vascular smooth muscle cells derived from different vascular bed. Gen Pharmacol, 1997, 28 (3): 387 -392.
4. Suga SI, Nakao K, Hosoda K et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and c-type natriuretic peptide. Endocrinology, 1992, 130 (1): 229-239.
5. Levin ER. Natriuretic peptide C-receptor: more than a clearance receptor. Am J Physiol, 1993, 264 (Endocrinol Metab 27): E483-E489.